Lilit Karapetyan

Also affiliated with Moffitt Cancer Center

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Partial tumor irradiation plus pembrolizumab in treating large advanced solid tumor metastases”.

Partial tumor irradiation plus pembrolizumab in treating large advanced solid tumor metastases

Journal of Clinical Investigation(2023)10.1172/jci162260

N/A

1.1DataRank · unranked

22 citations

Benjamin E. Onderdonk, Rebekah Dadey, Jared H. Hara, Lilit Karapetyan, Yuanyuan Zha +8 more

Antagonism of regulatory ISGs enhances the anti-melanoma efficacy of STING agonists

Frontiers in Immunology(2024)10.3389/fimmu.2024.1334769

N/A

0.373DataRank · unranked

11 citations

Jennifer L. Taylor, Jianmin Wang, Yali Zhang, Prashant Kumar Singh, Mark A. Ross +6 more

Expression of lymphoid structure-associated cytokine/chemokine gene transcripts in tumor and protein in serum are prognostic of melanoma patient outcomes

Frontiers in Immunology(2023)10.3389/fimmu.2023.1171978

N/A

0.360DataRank · unranked

10 citations

Hassan Abushukair, Aofei Li, Andrew Knight, Ayah Nedal Al Bzour, Ian MacFawn +16 more

Lead-in therapy targeting PD1 and/or LAG3 imposes distinct immune phenotypes in first-line treatment of metastatic melanoma

medRxiv(2025)10.1101/2025.11.04.25339499

N/A

0.165DataRank · unranked

2 citations

Anthony R. Cillo, Shuaichao Wang, Arivarasan Karunamurthy, Ryan Massa, Anjali Rohatgi +16 more

Blockade of LAG-3 and PD-1 leads to co-expression of cytotoxic and exhaustion gene modules in CD8+ T cells to promote antitumor immunity

Cell(2024)10.1016/j.cell.2024.06.036

N/A

0DataRank · unranked

157 citations

Carly Cardello, Feng Shan, Lilit Karapetyan, Sheryl Kunning, Cindy Sander +9 more

Differences in the pathological, transcriptomic, and prognostic implications of lymphoid structures between primary and metastatic cutaneous melanomas

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2024-009231

N/A

0DataRank · unranked

10 citations

Aofei Li, Danielle Vargas De Stefano, Hassan Abushukair, Ayah N. Al-Bzour, Andrew Knight +15 more

Interferon Biology and LAG-3 Shedding in PD-(L)1 plus LAG-3 Immunotherapy

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-3312

N/A

0DataRank · unranked

5 citations

Jason J. Luke, Lilit Karapetyan

1340 Lead-in therapy targeting PD1 and/or LAG3 distinguishes differential impacts upon the immune response in first-line treatment of metastatic melanoma

(2025)10.1136/jitc-2025-sitc2025.1340

N/A

0DataRank · unranked

0 citations

Anthony R. Cillo, Shuaichao Wang, Arivarasan Karunamurthy, Ryan Massa, Anjali Rohatgi +15 more

Radiation dose, schedule, and novel systemic targets for radio-immunotherapy combinations

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad118

N/A

0DataRank · unranked

25 citations

Uzoma K. Iheagwara, Adam C. Olson, Steven J. Chmura, Heath K Skinner, Jason J. Luke +1 more

Differential requirements for CD4+ T cells in the efficacy of the anti-PD-1+LAG-3 and anti-PD-1+CTLA-4 combinations in melanoma flank and brain metastasis models

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2023-007239

N/A

0DataRank · unranked

15 citations

Jiannong Li, Zhihua Chen, Paulo C. Rodrı́guez, Jay K. Mandula, Lilit Karapetyan +4 more

Defining the mechanisms of action and resistance to the anti-PD-1+LAG-3 and anti-PD-1+CTLA-4 combinations in melanoma flank and brain models

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.04.14.536907

N/A

0DataRank · unranked

0 citations

Jiannong Li, Zhihua Chen, Paulo C. Rodrı́guez, Jay K. Mandula, Lilit Karapetyan +4 more